Cost-effectiveness of occupational therapy for older adults: a protocol for an updated systematic review

被引:0
|
作者
Kaneko, Takao [1 ]
Nagayama, Hirofumi [2 ]
Ikeda, Kohei [2 ]
Nakamura, Takuto [2 ]
Niimi, Ayaka [3 ]
Inoue, Natsuki [4 ]
Takeda, Taisei [4 ]
Uchida, Junya [4 ]
机构
[1] Yamagata Prefectural Cent Hosp, Dept Rehabil, Yamagata, Japan
[2] Kanagawa Univ Human Serv, Dept Occupat Therapy, Yokosuka, Kanagawa, Japan
[3] Yokohama City Univ Med, Yokohama, Kanagawa, Japan
[4] Higashi Kanagawa Rehabil Hosp, Yokohama, Kanagawa, Japan
来源
BMJ OPEN | 2023年 / 13卷 / 12期
关键词
Systematic Review; HEALTH ECONOMICS; REHABILITATION MEDICINE; ECONOMIC EVALUATIONS; HEALTH-CARE; PEOPLE; QUALITY;
D O I
10.1136/bmjopen-2023-079318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe ageing populations in developed countries are a global concern, with increasing numbers of older adults facing physical, cognitive and psychological challenges, resulting in reduced quality of life and higher healthcare costs. Healthcare expenditure worldwide has been on the rise, especially among older adults, emphasising the importance of enabling independent living while reducing healthcare costs. Occupational therapy holds promising outcomes in promoting functional independence and enhancing the quality of life for older adults, but research on its cost-effectiveness remains limited. This systematic review aims to evaluate the recent evidence on the cost-effectiveness of occupational therapy interventions for older adults from a pragmatic perspective.Methods and analysisThis systematic review will cover full economic evaluations, including cost-effectiveness, cost-utility and cost-benefit analyses, by reviewing randomised and cluster randomised controlled trials. The participants will be aged over 65 years without disease or disability restrictions. Primary outcomes will be assessed using functional status and quality-of-life assessments. Studies published before July 2023 will be searched in PubMed, Web of Science and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases, with no language restrictions.Ethics and disseminationEthical approval is not required for this literature-based systematic review. The study's findings will update the evaluation of occupational therapy's cost-effectiveness in older adults and will be made public by publishing them in scholarly journals.PROSPERO registration numberCRD42023453558.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Cost-effectiveness of Occupational Therapy in Older People: Systematic Review of Randomized Controlled Trials
    Nagayama, Hirofumi
    Tomori, Kounosuke
    Ohno, Kanta
    Takahashi, Kayoko
    Yamauchi, Keita
    [J]. OCCUPATIONAL THERAPY INTERNATIONAL, 2016, 23 (02) : 103 - 120
  • [2] Cost-effectiveness of preventive occupational therapy for independent-living older adults
    Hay, J
    LaBree, L
    Luo, R
    Clark, F
    Carlson, M
    Mandel, D
    Zemke, R
    Jackson, J
    Azen, SP
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (08) : 1381 - 1388
  • [3] COST-EFFECTIVENESS OF INTERVENTIONS PREVENTING FALLS IN OLDER ADULTS: A SYSTEMATIC REVIEW
    Schmidt, M.
    Werbrouck, A.
    Verhaeghe, N.
    Putman, K.
    Annemans, L.
    Simoens, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S630 - S630
  • [4] Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults
    Loong, Desmond
    Pham, Ba'
    Amiri, Mohammadreza
    Saunders, Hailey
    Mishra, Sujata
    Radhakrishnan, Amruta
    Rodrigues, Myanca
    Yeung, Man Wah
    Mueller, Matthew P.
    Straus, Sharon E.
    Tricco, Andrea C.
    Isaranuwatchai, Wanrudee
    [J]. VALUE IN HEALTH, 2022, 25 (08) : 1439 - 1458
  • [5] The Cost-Effectiveness of Mobile Health (mHealth) Interventions for Older Adults: Systematic Review
    Ghani, Zartashia
    Jarl, Johan
    Berglund, Johan Sanmartin
    Andersson, Martin
    Anderberg, Peter
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (15) : 1 - 13
  • [6] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Nannan Li
    Dennis Cornelissen
    Stuart Silverman
    Daniel Pinto
    Lei Si
    Ingrid Kremer
    Sandrine Bours
    Robin de Bot
    Annelies Boonen
    Silvia Evers
    Joop van den Bergh
    Jean-Yves Reginster
    Mickaël Hiligsmann
    [J]. PharmacoEconomics, 2021, 39 : 181 - 209
  • [7] AN UPDATED SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF DRUGS FOR OSTEOPOROSIS
    Li, N.
    Cornelissen, D.
    Silverman, S.
    Pinto, D.
    Si, L.
    Kremer, I.
    Bours, S.
    Boonen, A.
    Evers, S.
    van den Bergh, J.
    Reginster, J. -Y.
    Hiligsmann, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S491 - S491
  • [8] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Li, Nannan
    Cornelissen, Dennis
    Silverman, Stuart
    Pinto, Daniel
    Si, Lei
    Kremer, Ingrid
    Bours, Sandrine
    de Bot, Robin
    Boonen, Annelies
    Evers, Silvia
    van den Bergh, Joop
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    [J]. PHARMACOECONOMICS, 2021, 39 (02) : 181 - 209
  • [9] Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review
    Koeser, Leonardo
    McCrone, Paul
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (02) : 171 - 182
  • [10] Cost-Effectiveness of Antiretroviral Therapy: A Systematic Review
    Gupta, Indrani
    Singh, Damini
    [J]. INDIAN JOURNAL OF PUBLIC HEALTH, 2020, 64 : 32 - 38